Carolyn Gaebler and Lisa Soleymani Lehmann, MD, PhD, MSc
The occasional required ethics course is not conveying to medical students that training institutions take ethics and the humanities seriously and consider them central to doctoring.
When a seriously ill mature minor and his parent disagree about his receiving an experimental intervention, who should decide what treatment he will receive?
Students more familiar with the quantifiable knowledge taught in medical and premedical curricula become aware that this perspective is not the only or even the most comprehensive way to see health, illness, and healing.
Distinctions between treatment and enhancement, and between supposedly authentic and inauthentic tools, often inform judgments about what is morally acceptable in sport.
Michael J. O’Brien, MD and William P. Meehan III, MD
It is unclear whether the decreased risk of injury associated with prohibiting a teenage boy from playing football outweighs the benefits to his health and well-being of allowing him to participate.
This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.